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ABSTRACT 
Background: Fluorescence-guided surgery (FGS) with 5-aminolevulinic acid (5-ALA) his 
proven to assist neurosurgeons to achieve a more complete brain tumour resection. However, 
5-ALA-guided surgery is limited since it is often difficult to distinguish the colour difference 
between the resected areas of malignant brain tumours from their background. Our aim was to 
evaluate which colour difference formula was the most optimal to distinguish between 
malignant brain tumors from the background healthy tissue using 5-ALA fluorescence. 
Materials and methods: 37 patients with a primary or secondary malignant brain tumour 
ingested 5-ALA before the surgery. A 400 nm light was used to excite the fluorescence. 
Surgical videos were recorded for all the patients and a total of 183 samples were obtained 
from the fluorescent areas and their respective backgrounds. Three colour differences 
formulas—contrast ratio (CR), CIELab (ΔE*) and CIEDE2000—were applied to the videos 
and compared using hot-cold maps. Baseline demographics, the tumour’s location, the 
tumour’s side, and tumour’s World Health Organisation (WHO) grade was also analysed for 
correlations relating to the fluorescence. Chi-square and the Student’s t-test were used for 
univariate relations. The three channels of the CIELAB colour space (L*, a* and b*) were 
analysed together and separately (since L* of fluorescent areas was significantly higher than 
the background). 
Results: ΔE* resulted in good discrimination of a* and b*, and moderate but acceptable 
discrimination of L*. CIEDE2000 distinguished differences in a* and b*, although, not in L*. 
The CR distinguished only L*, whereas the probability of discriminating a* and b* channels 
failed. Neither age, sex, tumour location, tumour size or the WHO grade influenced the a*, b* 
and L* colour values (p >0.05). Colour differences measured by ΔE* and CIEDE2000 
correlated together (r=0.99, p<0.01), whereas CR correlated only with ΔE (r=0.21, p=0.01) 
but not with CIEDE2000 (r=0.07, p=0.32). 
Conclusions: ΔE* obtained the best colour discrimination between the resected areas of 
malignant brain tumours and the background when compared to CR and CIEDE2000. 
Therefore, ΔE* may be the best formula to help neurosurgeons distinguish the colour 
differences when operating malignant brain tumours with 5-ALA fluorescence.  
Key words: 5-aminolevulinic acid, glioma surgery, colour perception, CIEDE2000, 
fluorescence 
 
 
INTRODUCTION 
Maximal tumour resection with minimal injury to the surrounding tissue remains the goal for 
neurological surgeons operating on malignant brain tumours [1–4]. Fluorescence-guided 
surgery (FGS), may assist in this matter as it allows better visualization of a patient’s brain 
tumours, despite brain shift caused by a prolonged surgery or neuronavigational limitations 
[5]. This allows the physician to perform a more optimal resection for not only for malignant 
gliomas but also for recurrent glioblastomas [5,6]. 5-aminolevulinic acid (5-ALA) is 
commonly used for FGS as it is a natural haemoglobin metabolite, can be easily administered 
orally and carries minimal side effects [7].  
After ingestion, it accumulates within malignant brain tissues and fluoresces in a violet-red 
colour after excitation with blue light. 
Unfortunately, despite the promise of 5-ALA-guided resection, it remains greatly limited 
since 5-ALA fluorescence is sometimes difficult be distinguished from the background 
healthy tissue. This is crucial since, in practice, the decision to resect a section of a tumor is 
determined largely by the background colour [2]. To the human eye, slightly different colors 
may not be able to be distinguished. Thus, to objectively measure color, the CIELAB color 
system is used to reliably express color in three quantitive values denoted: L*, a* and b*. 
Several colour difference formulas have been proposed including: contrast ratio (CR), 
CIELab (ΔE*) and CIEDE2000.  
ΔE* was the very first formula proposed by the International Commission on Illumination 
(CIE) to measure distance between colours. However, over time, they updated their colour 
difference formula to CIEDE2000 to account for non-uniformities in human colour vision. 
CIEDE2000 has also been established as the International Organization for Standardization 
(ISO) standard. However, these general recommendations may not be the most optimal to 
distinguish brain tumors due to the highly specific physical qualities of brain tissue and brain 
tumors. Studies have shown that color perception is highly unique depending on the part of 
the human body and tissue studied [8,9]. To our knowledge, no study has yet been done to 
determine of the best color difference formula(s) regarding brain tumors. 
We sought to evaluate which colour difference parameter was the most optimal to distinguish 
between malignant brain tumors and the background using 5-ALA fluorescence. To 
accomplish this, we utilized numerous color difference formulas (i.e. CR, ΔE* or 
CIEDE2000) on the neurosurgical recordings of patients with brain tumors. 
 
MATERIALS AND METHODS 
Patients  
37 patients with a brain tumour were prospectively collected (22 males and 15 females; age 
23-81 years, mean ±SD: 58.2 ±16.3, and median age: 64). These patients were treated at the 
Neurosurgery Department at the Medical University of Gdańsk in Gdańsk, Poland, from 
August 2015 to December 2019. We collected baseline demographic data (age and sex), 
tumour location (within the lobe and the hemisphere), histopathology, and the World Health 
Organisation (WHO) tumour grade. The protocol of the study was approved by the local 
bioethical committee (permission number NKBBN/98/2012). The study is a continuation of 
our previous observations and includes a similar methodology for colour analysis [2]. 
Surgery 
Four hours prior to anaesthesia, 5-ALA (Gliolan, Medac GmbH; Wedel, Germany) was given 
orally to each patient. Following craniotomy, MRI-based navigation helped to remove the 
gross parts of the tumour under white light. Diffusion tensor tractography highlighted white 
matter tracts (cerebrospinal tract or arcuate fasciculus) and limited resection of the tumours 
located near the eloquent areas.  
Afterwards, a blue light was used to identify the remaining tumour and a white light was 
turned on for further resection. The surgery was carried out in this way until the operating 
neurosurgeon deemed the tumour to be completely resected. In all the surgeries, the duration 
from 5-ALA intake to the end of surgical resection was about 9 hours.  
Equipment 
Preoperative Magnetic resonance imaging was performed on all patents (1.5 Tesla, according 
to the site-specific protocol, including contrast enhanced (CE) T1, T2-weighted, spectroscopy 
and diffusion weighed scenes). The StealthViz application (Medtronic Inc., Minneapolis) and 
StealthStation S7 navigation (Medtronic Navigation; Louisville, CO, USA) assisted all the 
surgeries. Blue-light filtering of the surgical microscope (OPMI Pentero with fluorescence kit 
BLU 400, Carl Zeiss, Germany) met the European Medical Device Directive 93/42/EEC 
requirements. The microscope included an integrated digital camera MKC-500HD (Ikegami 
Co.; Tokyo, Japan). Camera specifications were as follows: high-definition matrix 
1920x1080p, 54dB signal-to-noise ratio, sensitivity of F12 at 2000 lux/3200°K and a 1/3-inch 
CMOS image sensor. Light sensitivity and white balance remained constant at the default 
settings. Spectral sensitivity and light filtering in the microscope and camera were 
unattainable from the manufacturers. The excitation wavelength range was 400-410nm and 
the observation wavelength range was 620-710nm. Room luminance remained constant 
during the entire surgery and study. 
Surgical recordings were examined on a Dell U2410 32’’ monitor (1920x1200p, 16:10 
widescreen aspect ratio, 80000:1 dynamic contrast ratio, colour depth of 1.07 billion and 
100% coverage of CIE L*a*b* colour gamut 7). Shotcut software v.5.2.0 (Digia Inc.; Santa 
Clara, CA, USA) was used for video playback without any video filtering. 
Study design and colour analysis 
The neurosurgical recordings were watched and points of interest to be included into this 
study’s colorimetric evaluation were chosen if: (1) an area demonstrated fluorescence by the 
naked eye regardless of its future surgical removal and (2) if an area was delineated by the 
adjacent background by a different colour.  
The points of interests were chosen from the video. Then, Colour Contrast Analyser v.2.5 
(WAT Consortium, int’l) was used to probe the area with RGB colour model values. Both the 
fluorescent region and the corresponding background of the tumour was analysed in this way. 
Afterwards, the RGB model was transformed into the CIELAB colour space which consisted 
of three colour coordinates denoted L*, a* and b* (L* denotes lightness, a* describes a red or 
green value and b* describes a yellow or blue value).  
Using these values, the following formulas found colour differences from the same pool of 
samples: ΔE*, CIEDE2000 and Contrast Ratio (CR). ΔE* measures the difference between 
two colours (L*, a* and b*). CR compares relative luminance (i.e. all colours are converted to 
greyscale) and it is the key parameter distinguishing colours. CIEDE2000 is a complex 
formula taking into account several metrics to compensate for neutral colours, lightness, 
chroma and hue. 
CIEDE2000, ΔE and CR calculated colour differences and their formulas are presented 
below: 
 CIEDE2000 (CIE Publ. 142-2001, CIE S 014-6/E:2013) 
 ΔE* = √((L1-L2)^2+(a1-a2)^2+(b1-b2)^2 ) 
 CR = (L1 + 0.05) / (L2 + 0.05) 
where L1 and L2 represent relative lighter and darker colour luminance respectively; a1, b1 
and a1, b1 signify dimensions of lighter and darker colours respectively. 
ΔE*, CIEDE2000 and RGB to CIE 1976 L*a*b* transformations were calculated using an 
electronic spread sheet (Microsoft Office Excel 2010 for Windows). CR was calculated using 
Colour Contrast Analyser software. 
Statistical analysis 
Statistica Software v.10.0 (StatSoft Inc.; Tulsa, OK, USA), was used for performing Chi-
square, Student’s t-test and their non-parametric equivalents. Continuous variables are 
expressed as mean ± standard deviation (SD). A P value of <0.05 was considered statistically 
significant. Figure 1 illustrates the methodology of probing fluorescent areas and their 
surroundings. Figure 2 was created using Prism v.6.07 (GraphPad; La Jolla, CA, USA). Hot-
cold maps in Figure 3 were created using Past (Hammer and Harper, Øyvind Hammer, 
Natural History Museum, University of Oslo).  
Study objective 
Our aim was to evaluate various colour difference formulas (CR, ΔE* and CIEDE2000) that 
distinguish fluorescent areas from the background. We attempted this by analysing the area of 
CIELAB colour space under 400 nm illumination and probed fluorescent points and their 
background. 
 
RESULTS 
The clinical course and outcome were not the scope of the study. 27 patients (73.0%) had 
glioblastoma and 2 (5.4%) had gliosarcoma. Out of the primary brain tumours, all were 
malignant except for one patient with gemistic astrocytoma (WHO 2 grade). Out of the total 
37 patients, there were 14 (37.8%) surgeries of recurrent or progressive tumours. The most 
common locations of the tumour were at the temporal lobe (n=16, 43.2%) and the frontal lobe 
(n=9, 24.3%). We obtained 183 samples of fluorescent areas and 183 samples of their 
respective background. The detailed chart of sampled values is presented on Supplementary 
Table 1. 
The results of all the CIELAB colour space channels are illustrated on Figure 2. 
 
Colour difference 
ΔE and CIEDE2000 correlated together (r=0.99, p<0.01). CR correlated only with ΔE 
(r=0.21, p=0.01) but not with CIEDE2000 (r=0.07, p=0.32). Age, sex, the number of samples, 
brain hemisphere, location of the tumour and glioblastoma histopathology did not influence 
the fluorescent areas or their background colour values (a*, b* and L*) (P always >0.05). 
Descriptive statistics of all colour difference parameters are presented on Table 1 and Figure 3 
illustrates those findings. ΔE resulted in good discrimination of a* and b*, and moderate but 
acceptable discrimination of L*. CR distinguished only L*, whereas the probability of 
discriminating a* and b* channels failed. CIEDE2000 distinguished differences in a* and b* 
axes, however, not in L*.  
 
DISCUSSION 
Key findings: 
We found that ΔE* best distinguished colour differences between the resected areas of 
malignant brain tumours and the background with 5-ALA fluorescence compared to other 
established colour difference formulas, namely CIEDE2000 and CR. By utilizing this optimal 
colour difference formula for intracranial tumours, neurosurgeons can further appreciate and 
enjoy the benefits of 5-ALA FGS by performing more complete tumour resections. Our 
findings are clinically profound since a greater extent of tumour resection may lead to several 
favourable prognostic implications for the patient. Even in patients with glioblastoma—a 
tumour with an especially poor prognosis—a greater extent of resection is still a proven 
benefit to patients [10–12]. To our best knowledge, this study is the first to compare the 
colour difference formulas among intracranial tumours. Moreover, our findings challenge the 
current ISO colour difference standard (i.e. CIEDE2000, which is recommended by the CIE).  
Context 
Gómez-Polo C et al—on their colour experiments conducted on the human gingiva— found 
that CIEDE2000 imitated colour differences better than ΔE*, however, in a later experiment 
found that both formulas reflected color differences in a similar fashion [9,13]. Our results 
disagree with Gómez-Polo C et al as we found that ΔE* best distinguished colour differences, 
however, we reiterate that our experiments were conducted on malignant intracranial tumours 
which may express 5-ALA fluorescence much different colours than the human gingiva. 
Therefore, we do not discredit CIEDE2000, but postulate that it may not be the most superior 
in distinguishing colour differences with malignant brain tumours.  
In our previous study on 5-ALA, we proved that surgeons make a decision of tumour 
resection based on colour contrast (like CR), and not on colour fluorescence [2]. Therefore, in 
our study, we compared the CR with ΔE*and CIEDE2000. In this study, the CR formula 
distinguished colour difference the best in the L* section of colour space (the shades from 
black to white) compared to ΔE*and CIEDE2000.  However, we realize that since CR is 
calculated solely on L*, it has a limited use when discriminating other colour parameters (e.g. 
pink fluorescence from a grey background).  
A 2011 study on 5-ALA first explored the advantages of measuring 5-ALA-induced 
fluorescent-metabolites in vivo [14]. Therefore, our study adopted a similar method as the 
spectra of colours were measured intraoperatively. Their study also concluded that 5-ALA 
may be used for not only high-grade glioma, but other tumours as well. Our results, support 
these findings as 5-ALA was able to discriminate between normal and malignant tumour 
tissue in a variety of tumours (i.e. glioblastoma, anaplastic oligodendroglioma and anaplastic 
astrocytoma). 
Limitations 
We realize that there is an inherent challenge in measuring colour difference due to the 
heterogeneous perception of colour among every individual that is problematic to overcome. 
However, the formulas used in our study to distinguish colour differences are established and 
reproducible. 
Moreover, it is possible that blood or other organic brain debris might have covered parts of 
the fluorescing tumour, making colour analysis complicated. Removing unwanted material 
and preserving a clear view of the operating field is the responsibility of the operating 
neurosurgeon. We confirm that the neurosurgeons operating on the tumours included in the 
study had more than 15 years of neurosurgical experience at a university hospital, and thus, 
assume that they maintained an adequate view of the surgical field at least for the purposes of 
this study. 
Future directions 
In our study, both fluorescence and background colour space sections partially overlapped 
(see Figure 2). Therefore, we recommend that future studies on 5-ALA fluorescence include a 
more specific section of colour space to further highlight fluorescence differences.  
We recommend that confirmatory studies be done in other centres around the world to help 
determine if slight differences in colour perception among populations may be significant 
enough to warrant colour research specific to a particular population or sub-population [15]. 
Of note, the neurosurgeons that performed that surgeries were of Polish descent. 
Our study was conducted on an adult population. Future studies may conduct a similar study 
on a paediatric population as current research suggests that 5-ALA assisted surgery may aid in 
the resection of paediatric brain tumours as well [16]. 
Clinical implications 
Several studies have demonstrated that the human visual system may be augmented by 
fluorescence targeting with 5-ALA and lead to a more extensive tumour resection [17–20] 
Fortunately, the cost of FGS is relatively low when compared to intraoperative magnetic 
resonance imaging (which has proven to maximize tumour resection) giving FGS an 
economical and practical advantage [21]. FGS with 5-ALA is one of the most innovative 
treatments in contemporary neurological surgery as it offers the surgeon intraoperative 
visualization of the tumour to a much greater extent than traditional white-light microscopy. 
By studying which mathematical formula(s) may best distinguish healthy tissue from 
malignant tissue, neurosurgeons may be empowered to excise a greater extent of the residual 
tumour tissue while preserving healthy tissue. FGS with 5-ALA has proven to be more 
effective than conventional neuronavigation-guided neurosurgery in identifying tumour 
margins, enhancing the extent of malignant tumour resections, promising a longer 
progression-free survival and increasing the quality of life of patients [22–24]. 
 
CONCLUSIONS 
In our study ΔE* best distinguished fluorescent areas from the background compared to 
CIEDE2000 and CR. Therefore, we recommend ΔE*to be used by neurological surgeons 
operating on intracranial tumours as it discriminates colour differences most optimally. 
 
Acknowledgements 
We thank Mr. Aleksander Och for his assistance throughout our study. 
 
REFERENCES 
[1] Szmuda T, Rogowska M, Słoniewski P, Abuhaimed A, Szmuda M, Springer J, et al. 
Frontal aslant tract projections to the inferior frontal gyrus. Folia Morphol (Warsz) 
2015. doi:10.5603/FM.a2017.0039. 
[2] Szmuda T, Słoniewski P, Olijewski W, Springer J, Waszak PM. Colour contrasting 
between tissues predicts the resection in 5-aminolevulinic acid-guided surgery of 
malignant gliomas. J Neurooncol 2015. doi:10.1007/s11060-015-1750-0. 
[3] Krakowiak M, Słoniewski P, Dzierżanowski J, Szmuda T. Future of the nerve fibres 
imaging: tractography application and development directions. Folia Morphol (Warsz) 
2015;74:290–4. doi:10.5603/FM.2015.0044. 
[4] Yu Q, Lin K, Liu Y, Li X. Clinical Uses of Diffusion Tensor Imaging Fiber Tracking 
Merged Neuronavigation with Lesions Adjacent to Corticospinal Tract : A 
Retrospective Cohort Study. J Korean Neurosurg Soc 2019. 
doi:10.3340/jkns.2019.0046. 
[5] Hadjipanayis CG, Widhalm G, Stummer W. What is the surgical benefit of utilizing 5-
aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? 
Neurosurgery 2015;77:663–73. doi:10.1227/NEU.0000000000000929. 
[6] Lu VM, Jue TR, McDonald KL, Rovin RA. The Survival Effect of Repeat Surgery at 
Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis. 
World Neurosurg 2018;115:453-459.e3. doi:10.1016/j.wneu.2018.04.016. 
[7] Collaud S, Juzeniene A, Moan J, Lange N. On the selectivity of 5-aminolevulinic acid-
induced protoporphyrin IX formation. Curr Med Chem - Anti-Cancer Agents 
2004;4:301–16. doi:10.2174/1568011043352984. 
[8] Ling F, Paul E, Furzer R. Colour difference of subcutaneous fat and palmar fat pad in 
open carpal tunnel release. ANZ J Surg 2014;84:856–60. doi:10.1111/ans.12754. 
[9] Gómez-Polo C, Montero J, Gómez-Polo M, Martin Casado A. Comparison of the 
CIELab and CIEDE 2000 Color Difference Formulas on Gingival Color Space. J 
Prosthodont 2017. doi:10.1111/jopr.12717. 
[10] Haj A, Doenitz C, Schebesch KM, Ehrensberger D, Hau P, Putnik K, et al. Extent of 
resection in newly diagnosed glioblastoma: Impact of a specialized neuro-oncology 
care center. Brain Sci 2018;8. doi:10.3390/brainsci8010005. 
[11] Shonka NA, Aizenberg MR. Extent of Resection in Glioblastoma. J Oncol Pract 
2017;13:641–2. doi:10.1200/jop.2017.027599. 
[12] Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. 
Extent of resection and survival in glioblastoma multiforme: Identification of and 
adjustment for bias. Neurosurgery 2008;62:564–74. 
doi:10.1227/01.neu.0000317304.31579.17. 
[13] Gómez-Polo C, Muñoz MP, Lorenzo Luengo MC, Vicente P, Galindo P, Martín 
Casado AM. Comparison of the CIELab and CIEDE2000 color difference formulas. J 
Prosthet Dent 2016;115:65–70. doi:10.1016/j.prosdent.2015.07.001. 
[14] Valdés PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, et al. Quantitative 
fluorescence in intracranial tumor: implications for ALA-induced PpIX as an 
intraoperative biomarker. J Neurosurg 2011;115:11–7. doi:10.3171/2011.2.JNS101451. 
[15] Webster MA, Webster SM, Bharadwaj S, Verma R, Jaikumar J, Madan G, et al. 
Variations in normal color vision III Unique hues in Indian and United States 
observers. J Opt Soc Am A 2002;19:1951. doi:10.1364/josaa.19.001951. 
[16] Schwake M, Schipmann S, Müther M, Köchling M, Brentrup A, Stummer W. 5-ALA 
fluorescence–guided surgery in pediatric brain tumors—a systematic review. Acta 
Neurochir (Wien) 2019;161:1099–108. doi:10.1007/s00701-019-03898-1. 
[17] Suero Molina E, Schipmann S, Stummer W. Maximizing safe resections: the roles of 5-
aminolevulinic acid and intraoperative MR imaging in glioma surgery—review of the 
literature. Neurosurg Rev 2019;42:197–208. doi:10.1007/s10143-017-0907-z. 
[18] Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, et al. 5-
Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely 
infiltrating gliomas with nonsignificant contrast enhancement. Cancer 2010;116:1545–
52. doi:10.1002/cncr.24903. 
[19] Roberts DW, Valdés PA, Harris BT, Fontaine KM, Hartov A, Fan X, et al. 
Coregistered fluorescence-enhanced tumor resection of malignant glioma: 
Relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, 
magnetic resonance imaging enhancement, and neuropathological parameters: Clinical 
article. J Neurosurg 2011;114:595–603. doi:10.3171/2010.2.JNS091322. 
[20] Floeth FW, Stummer W. The value of metabolic imaging in diagnosis and resection of 
cerebral gliomas. Nat Clin Pract Neurol 2005;1:62–3. doi:10.1038/ncpneuro0043. 
[21] Eljamel MS, Mahboob SO. The effectiveness and cost-effectiveness of intraoperative 
imaging in high-grade glioma resection; a comparative review of intraoperative ALA, 
fluorescein, ultrasound and MRI. Photodiagnosis Photodyn Ther 2016;16:35–43. 
doi:10.1016/j.pdpdt.2016.07.012. 
[22] Zhao S, Wu J, Wang C, Liu H, Dong X, Shi C, et al. Intraoperative Fluorescence-
Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid-
Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies. 
PLoS One 2013;8. doi:10.1371/journal.pone.0063682. 
[23] Su X, Huang QF, Chen HL, Chen J. Fluorescence-guided resection of high-grade 
gliomas: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther 
2014;11:451–8. doi:10.1016/j.pdpdt.2014.08.001. 
[24] Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. 
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant 
glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–
401. doi:10.1016/S1470-2045(06)70665-9. 
 
(Table 1) 
 
Value 
Mean 
 
Medi
an 
 
Mini
mum 
 
Maxi
mum 
 
Lowe
r 
quarti
le 
 
Upper 
quartile 
 
Stand
ard 
deviat
ion 
 
Standard  
error of 
mean 
 
foreground L* 
 
65.80 66.67 30.40 93.97 59.81 72.86 11.81 0.873025 
<0.01 
background L* 
 
45.19 45.62 11.01 72.47 37.47 53.03 11.26 0.832113 
fluorescence a* 
 
51.03 49.12 
-
11.93 
97.30 38.06 64.56 20.87 1.542679 
<0.01 
background a* 
 
-3.37 -5.78 
-
28.73 
49.91 
-
13.87 
4.3332 14.76 1.090750 
fluorescence b* 
 
-22.55 
-
24.69 
-
61.88 
20.67 
-
33.05 
-11.38 17.90 1.323546 
<0.01 
background b* 
 
9.84 13.53 
-
58.39 
44.82 0.27 22.49 18.82 1.391401 
ΔE 
 
42.51 41.55 14.10 78.66 30.58 55.17 14.82 1.096059  
contrast ratio 
(CR) 
 
2.11 1.90 1.00 4.80 1.70 2.50 0.65 0.047958  
CIEDE2000 
 
66.10 65.19 15.15 
145.0
7 
47.41 83.21 25.49 1.884512  
Table 1. Colour parameters and colour difference parameters between the fluorescent areas 
and the background. L*, a* and b* are CIELAB colour space values; colour difference was 
expressed by means of ΔE, contrast ratio (CR) and CIEDE2000. 
 
Figure 1. This illustration shows how colour parameters were obtained and analysed from the 
surgery. 
(A) The view of the neurosurgical operative area illuminated under normal white-light.  
(B) The same view of the operative area, however, illuminated by a 400nm blue light so that 
the fluorescence indicated the tumour (pink arrow on B).  
(C) A picture was taken and was analysed on the computer; the fluorescence (pink arrow) and 
the background (grey arrow) were chosen and the were coded on the RGB colour space. The 
contrast ratio was calculated automatically by the software (red rectangle). 
 Figure 2. Colours of fluorescing areas and the surrounding background in the three channels 
of the CIELAB colour space: a* (green (-) to red (+)), b* (blue (-) to yellow (+)) and L* for 
lightness from black to white. Since all three channels could not be represented feasibly on 
one three-dimensional graph (A) represents a* and b* while (B) represents only L* on the 
CIELAB colour space. Both (A) and (B) show a difference in the colour of the background 
(black crossed square) and the florescence (violet encircled dots), however, there is also 
overlap between the two in L*, a* and b*. 
(A) Most of the fluorescent areas were located in Quadrant III (the purple area) while the 
background colours were located mostly in Quadrant I (the green area). 
(B) The lightness (*L) of most of the fluorescent areas was higher than its background.  
Abbreviations: CIELAB – colour space defined by the International Commission on 
Illumination. 
 
Figure 3. Hot-cold probability maps show to what extent the contrast ratio (CR), CIEDE2000 
and ΔE distinguished colour differences in the three channels of the CIELAB colour space 
(L*, a* and b*). One may consider “solid or more distinct colour bands” to illustrate 
significant probabilities (e.g. ΔE for a*, b* and L*) while “scattered colours” illustrate non-
significant probabilities (CIEDE2000 for L* and CR for a* and b*). 



